$318.0M in CY2024 Part D spend198K claims · 32K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Imatinib used for?
Imatinib targets specific kinase enzymes involved in cancer cell growth and proliferation.
Is there a generic for Imatinib?
Yes. 24 ANDAs filed at FDA, 12 generic manufacturers currently shipping.
How much does my plan pay for Imatinib?
Across 329 Part D plans, Imatinib averages $1.18/unit (NADAC). Lowest available: $0.827/unit. Highest in distribution: $3.21/unit.
Is Imatinib on the FDA shortage list?
No. Imatinib is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.